Enzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticles

International Journal of Pharmaceutics

Volumn 413, Issue 1-2, 2011, Pages 10-18

  Clark, Meredith R ^a   Aliyar, Hyder A ^a   Lee, Chang Won ^a   Jay, Julie I ^b   Gupta, Kavita M ^a   Watson, Karen M ^c   Stewart, Russell J ^a   Buckheit, Robert W ^c   Kiser, Patrick F ^a,b  

^a University of Utah   (United States)

^b 301 Skaggs Hall   (United States)

^c ImQuest Biosciences   (United States)

Author keywords

HIV; Microbicide; Microgel; Prostate specific antigen; Semen; Triggered release

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROSTATE SPECIFIC ANTIGEN; TOLEVAMER;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE MICROPARTICLE; MICROEMULSION; PRIORITY JOURNAL; SEMINAL PLASMA; SPERM;

CROSS-LINKING REAGENTS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; FLUORESCEIN-5-ISOTHIOCYANATE; GELS; HELA CELLS; HIV FUSION INHIBITORS; HIV INFECTIONS; HIV-1; HUMANS; MALE; PARTICLE SIZE; PEPTIDES; POLYSTYRENES; PROSTATE-SPECIFIC ANTIGEN; SEMEN;

EID: 79958006022     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.04.004     Document Type: Article

References (41)

1. F. Albericio Orthogonal protecting groups for N(alpha)-amino and C-terminal carboxyl functions in solid-phase peptide synthesis Biopolymers 55 2000 123 139
2. S.P. Balk, Y.J. Ko, and G.J. Bubley Biology of prostate-specific antigen J. Clin. Oncol. 21 2003 383 391 (Pubitemid 46606169)
3. M.R. Boyd, K.R. Gustafson, J.B. McMahon, R.h. Shoemaker, B.R. O'Keefe, T. Mori, R.J. Gulakowski, L. Wu, M.I. Rivera, C.M. Laurencot, M.J. Currens, J.H. Cardellina, R.W.J. Buckheit, P.l. Nara, L.K. Pannell, R.C. Sowder, and L.E. Henderson Discovery of cyanovirin-N, a novel human immunodefiency virus - inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to micbrocide development Antimicrob. Agents Chemotherapy 41 1997 1521 1530 (Pubitemid 27289680)
4. B.J. Catalone, S.R. Miller, M.L. Ferguson, D. Malamud, T. Kish-Catalone, N.J. Thakkar, F.C. Krebs, M.K. Howett, and B. Wigdahl Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G Biomed. Pharmacother. 59 2005 430 437 (Pubitemid 41383836)
5. H. Chakraborty, P.K. Sen, R.W. Helms, P.L. Vernazza, S.A. Fiscus, J.J. Eron, B.K. Patterson, R.W. Coombs, J.N. Krieger, and M.S. Cohen Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model Aids 15 2001 621 627 (Pubitemid 32281358)
6. X. Chen, Z.-T. Yu, J.-S. Chen, and B. Yang In situ hydrothermal preparation of CdS/polymer composite particles with cadmium-containing polymer latexes Mater. Lett. 58 2003 384 386
7. G.S. Coombs, R.C. Bergstrom, J.L. Pellequer, S.I. Baker, M. Navre, M.M. Smith, J.A. Tainer, E.L. Madison, and D.R. Corey Substrate specificity of prostate-specific antigen (PSA) Chem. Biol. 5 1998 475 488 (Pubitemid 28436726)
8. S.R. Denmeade, C.M. Jakobsen, S. Janssen, S.R. Khan, E.S. Garrett, H. Lilja, S.B. Christensen, and J.T. Isaacs Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer J. Natl. Cancer Inst. 95 2003 990 1000 (Pubitemid 36896716)
9. S.R. Denmeade, W. Lou, J. Lovgren, J. Malm, H. Lilja, and J.T. Isaacs Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen Cancer Res. 57 1997 4924 4930 (Pubitemid 27469004)
10. S.R. Denmeade, A. Nagy, J. Gao, H. Lilja, A.V. Schally, and J.T. Isaacs Enzymic activation of a doxorubicin-peptide prodrug by prostate-specific antigen Cancer Res. 58 1998 2537 2540 (Pubitemid 28275422)
11. P.S. Fletcher, G.S. Wallace, P.M. Mesquita, and R.J. Shattock Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants Retrovirology 3 2006 46
12. A.R. Geonnotti, and D.F. Katz Dynamics of HIV neutralization by a microbicide formulation layer: biophysical fundamentals and transport theory Biophys. J. 91 2006 2121 2130 (Pubitemid 44352395)
13. S.L. Goh, N. Murthy, M. Xu, and J.M. Frechet Cross-linked microparticles as carriers for the delivery of plasmid DNA for vaccine development Bioconjug. Chem. 15 2004 467 474 (Pubitemid 38657851)
14. R.H. Gray, M.J. Wawer, R. Brookmeyer, N.K. Sewankambo, D. Serwadda, F. Wabwire-Mangen, T. Lutalo, X. Li, T. vanCott, and T.C. Quinn Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda Lancet 357 2001 1149 1153 (Pubitemid 32378686)
15. K.M. Gupta, S.R. Barnes, R.A. Tangaro, M.C. Roberts, D.H. Owen, D.F. Katz, and P.F. Kiser Temperature and pH sensitive hydrogels: an approach towards smart semen-triggered vaginal microbicidal vehicles J. Pharm. Sci. 96 2007 670 681 (Pubitemid 46466087)
16. F. Hladik, P. Sakchalathorn, L. Ballweber, G. Lentz, M. Fialkow, D. Eschenbach, and M.J. McElrath Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1 Immunity 26 2007 257 270 (Pubitemid 46329434)
17. K. Honey Microbicide trial screeches to a halt J. Clin. Invest. 117 2007 1116 (Pubitemid 46718395)
18. Q. Hu, I. Frank, V. Williams, J.J. Santos, P. Watts, G.E. Griffin, J.P. Moore, M. Pope, and R.J. Shattock Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue J. Exp. Med. 199 2004 1065 1075 (Pubitemid 38619903)
19. T.J. Ketas, S.M. Schader, J. Zurita, E. Teo, V. Polonis, M. Lu, P.J. Klasse, and J.P. Moore Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes Virology 364 2007 431 440 (Pubitemid 46873705)
20. S.L. Lard-Whiteford Recommendations for the preclinical development of topical microbicides for prevention of HIV transmission: an update J. Acquir. Immune Defic. Syndr. 36 2004 541 552 (Pubitemid 38544502)
21. H. Lilja Biology of prostate-specific antigen Urology 62 2003 27 33 (Pubitemid 37371887)
22. M. Matsumura, A.S. Bhatt, D. Andress, N. Clegg, T.K. Takayama, C.S. Craik, and P.S. Nelson Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries. Prostate (New York, NY, United States) 62 2005 1 13 (Pubitemid 39614288)
23. J.A. Moss, S. Stokols, M.S. Hixon, F.T. Ashley, J.Y. Chang, and K.D. Janda Solid-phase synthesis and kinetic characterization of fluorogenic enzyme-degradable hydrogel cross-linkers Biomacromolecules 7 2006 1011 1016 (Pubitemid 43670785)
24. A.R. Neurath, N. Strick, and Y.Y. Li Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides BMC Infect. Dis. 2 2002 27
25. A.R. Neurath, N. Strick, and Y.Y. Li Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides BMC Infect. Dis. 6 2006 150
26. M. Nyindo Complementary factors contributing to the rapid spread of HIV-I in sub-Saharan Africa: a review East Afr. Med. J. 82 2005 40 46 (Pubitemid 44204239)
27. A. Peter, H. Lilja, A. Lundwall, and J. Malm Semenogelin I and semenogelin II, the major gel-forming proteins in human semen, are substrates for transglutaminase Eur. J. Biochem. 252 1998 216 221 (Pubitemid 28101996)
28. G. Ramjee, R. Govinden, N.S. Morar, and A. Mbewu South Africa's experience of the closure of the cellulose sulphate microbicide trial PLoS Med. 4 2007 e235
29. G. Ramjee, R. Shattock, S. Delany, I. McGowan, N. Morar, and M. Gottemoeller Microbicides 2006 conference AIDS Res. Ther. 3 2006 25
30. M. Ratterree, A. Gettie, V. Williams, S. Malenbaum, A.R. Neurath, C. Cheng-Mayer, and J. Blanchard Safety and distribution of cellulose acetate 1,2-benzenedicarboxylate (CAP), a candidate anti-HIV microbicide in rhesus macaques Aids 19 2005 1595 1599 (Pubitemid 41502671)
31. S. Rehault, M. Brillard-Bourdet, L. Bourgeois, G. Frenette, L. Juliano, F. Gauthier, and T. Moreau Design of new and sensitive fluorogenic substrates for human kallikrein hK3 (prostate-specific antigen) derived from semenogelin sequences Biochim. Biophys. Acta 1596 2002 55 62 (Pubitemid 34450840)
32. P. Rejmanova, J. Labsky, and J. Kopecek Aminolyses of monomeric and polymeric 4-nitrophenyl esters of N-methacryloylamino acids Makromol. Chem. 178 1977 2159 2168
33. R.J. Shattock, and J.P. Moore Inhibiting sexual transmission of HIV-1 infection Nat. Rev. Microbiol. 1 2003 25 34
34. A. Stone Microbicides: a new approach to preventing HIV and other sexually transmitted infections Nat. Rev. Drug Discov. 1 2002 977 985 (Pubitemid 37361603)
35. N. Thieriet, J. Alsina, E. Giralt, F. Guibe, and F. Albericio Use of Alloc-amino acids in solid-phase peptide synthesis Tandem deprotection-coupling reactions using neutral conditions Tetrahedron Lett. 38 1997 7275 7278 (Pubitemid 27454234)
36. C.C. Tsai, P. Emau, Y. Jiang, M.B. Agy, R.J. Shattock, A. Schmidt, W.R. Morton, K.R. Gustafson, and M.R. Boyd Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models AIDS Res. Hum. Retroviruses 20 2004 11 18 (Pubitemid 38147172)
37. UNAID/WHO, 2007. AIDS Epidemic Update. United Nations.
38. R.S. Veazey, P.J. Klasse, S.M. Schader, Q. Hu, T.J. Ketas, M. Lu, P.A. Marx, J. Dufour, R.J. Colonno, R.J. Shattock, M.S. Springer, and J.P. Moore Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion Nature 438 2005 99 102 (Pubitemid 41599827)
39. T.J. Wang, H.G. Rittenhouse, R.L. Wolfert, C.M. Lynne, and N.L. Brackett PSA concentrations in seminal plasma Clin. Chem. 44 1998 895 896
40. B.K. Warrier, E. Kostoryz, and C.H. Lee Biocompatibility of components of a female controlled drug delivery system J. Biomed. Mater. Res. 71A 2004 209 216 (Pubitemid 39362900)
41. S.K. Whitmore, A.J. Satcher, and S. Hu Epidemiology of HIV/AIDS among non-Hispanic black women in the United States J. Natl. Med. Assoc. 97 2005 19S 24S (Pubitemid 40967391)